title: Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies.
abstract: Parts 1 and 2 of this 3-part series provided an overview of the epidemiology, visible patterns, and important considerations for clinical and laboratory evaluation of acne vulgaris (AV) in adult women and reviewed the role of proper skin care and topical therapies in this patient population. In Part 3, oral therapies including combination oral contraceptives, spironolactone, antibiotics, and isotretinoin are discussed along with important considerations that clinicians should keep in mind when selecting oral agents for management of AV in adult women.
authors.affiliation: Touro University College of Osteopathic Medicine, Henderson, Nevada, and Las Vegas Dermatology, Nevada, USA.
authors.forename: James Q
authors.initials: JQ
authors.lastname: Del Rosso
authors.affiliation: Private practice, Birmingham, Alabama, USA.
authors.forename: Julie C
authors.initials: JC
authors.lastname: Harper
authors.affiliation: Private practice, Boston, Massachusetts, USA.
authors.forename: Emmy M
authors.initials: EM
authors.lastname: Graber
authors.affiliation: Penn State University Medical Center, Hershey, USA.
authors.forename: Diane
authors.initials: D
authors.lastname: Thiboutot
authors.affiliation: Department of Dermatology, Mount Sinai St. Luke's-Roosevelt and Beth Israel Medical Center of the Icahn School of Medicine at Mount Sinai, New York, New York, USA.
authors.forename: Nanette B
authors.initials: NB
authors.lastname: Silverberg
authors.affiliation: University of California, San Diego School of Medicine, USA and Rady Children's Hospital, San Diego, California, USA.
authors.forename: Lawrence F
authors.initials: LF
authors.lastname: Eichenfield
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D003276:Contraceptives, Oral / Q000008:administration & dosage; D003879:Dermatologic Agents / Q000008:administration & dosage; D005260:Female; D006801:Humans; D017410:Practice Guidelines as Topic; D012393:Rosacea / Q000188:drug therapy*; D012955:Societies, Medical; D014481:United States; D016387:Women's Health
chemical_list: D000900:Anti-Bacterial Agents; D003276:Contraceptives, Oral; D003879:Dermatologic Agents